The dynamics of the malignant pleural mesothelioma market are anticipated to change in the coming years owing to the increasing awareness and expected increase in investment in the R&D activities.
The overall immune thrombocytopenia market is anticipated to surge owing to the increasing prevalence of the disease along with promising emerging pipeline therapy during the forecasted period
The respiratory syncytial virus market is expected to show positive growth, mainly attributed to the increasing incident cases and also, the launch of upcoming therapies during the forecast
The hidradenitis suppurativa market is expected to grow at a faster rate due to increased awareness and increase in novel discoveries. The expected launch of potential emerging therapies will